New Preclinical Results Are Encouraging: How Much Can Vaxart Climb?
VXRT

Vaxart, Inc. ($VXRT) – a well-known clinical stage biotechnology company developing oral recombinant vaccines that are administered via tablets rather than injections – is breaking the news this morning. The COVID-19 vaccine candidate has shown encouraging results in preclinical research. Vaxart is now announcing a pre-publication of a manuscript on this matter named: “Preclinical Studies…

Sorrento Therapeutics Seems to Aim for a High Risk, High Reward Principle
SRNE

Sorrento Therapeutics (Ticker: SRNE) acquired SmartPharm this week for $18.6 million. The pharmaceutical company offered approximately 1.76 million shares to SmartPharm for $10.60 each. The motivation for this is to support efforts to further develop antibody treatments for COVID-19 and other diseases. Sorrento claims it has an antibody that grabs and then blocks the virus…